BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27826056)

  • 1. Prognosis of patients with chronic hepatitis B in France (2008-2013): A nationwide, observational and hospital-based study.
    Mallet V; Hamed K; Schwarzinger M
    J Hepatol; 2017 Mar; 66(3):514-520. PubMed ID: 27826056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of alcohol use disorders on the burden of chronic hepatitis C in France, 2008-2013: A nationwide retrospective cohort study.
    Schwarzinger M; Baillot S; Yazdanpanah Y; Rehm J; Mallet V
    J Hepatol; 2017 Sep; 67(3):454-461. PubMed ID: 28396173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis of French COVID-19 patients with chronic liver disease: A national retrospective cohort study for 2020.
    Mallet V; Beeker N; Bouam S; Sogni P; Pol S;
    J Hepatol; 2021 Oct; 75(4):848-855. PubMed ID: 33992699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes poses a higher risk of hepatocellular carcinoma and mortality in patients with chronic hepatitis B: A population-based cohort study.
    Shyu YC; Huang TS; Chien CH; Yeh CT; Lin CL; Chien RN
    J Viral Hepat; 2019 Jun; 26(6):718-726. PubMed ID: 30739359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 2 diabetes and hepatocellular carcinoma: a case-control study in patients with chronic hepatitis B.
    Li Q; Li WW; Yang X; Fan WB; Yu JH; Xie SS; Liu L; Ma LX; Chen SJ; Kato N
    Int J Cancer; 2012 Sep; 131(5):1197-202. PubMed ID: 22052244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis delta-associated mortality in HIV/HBV-coinfected patients.
    Béguelin C; Moradpour D; Sahli R; Suter-Riniker F; Lüthi A; Cavassini M; Günthard HF; Battegay M; Bernasconi E; Schmid P; Calmy A; Braun DL; Furrer H; Rauch A; Wandeler G;
    J Hepatol; 2017 Feb; 66(2):297-303. PubMed ID: 27746337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality related to chronic hepatitis B and chronic hepatitis C in France: evidence for the role of HIV coinfection and alcohol consumption.
    Marcellin P; Pequignot F; Delarocque-Astagneau E; Zarski JP; Ganne N; Hillon P; Antona D; Bovet M; Mechain M; Asselah T; Desenclos JC; Jougla E
    J Hepatol; 2008 Feb; 48(2):200-7. PubMed ID: 18086507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Causes of death in people with chronic HBV infection: A population-based cohort study.
    Montuclard C; Hamza S; Rollot F; Evrard P; Faivre J; Hillon P; Di Martino V; Minello A
    J Hepatol; 2015 Jun; 62(6):1265-71. PubMed ID: 25625233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic hepatitis B: a long-term retrospective cohort study of disease progression in Shanghai, China.
    Xu B; Hu DC; Rosenberg DM; Jiang QW; Lin XM; Lu JL; Robinson NJ
    J Gastroenterol Hepatol; 2003 Dec; 18(12):1345-52. PubMed ID: 14675261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B.
    Wong GL; Chan HL; Wong CK; Leung C; Chan CY; Ho PP; Chung VC; Chan ZC; Tse YK; Chim AM; Lau TK; Wong VW
    J Hepatol; 2014 Feb; 60(2):339-45. PubMed ID: 24128413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes mellitus is an independent prognostic factor for major liver-related outcomes in patients with cirrhosis and chronic hepatitis C.
    Elkrief L; Chouinard P; Bendersky N; Hajage D; Larroque B; Babany G; Kutala B; Francoz C; Boyer N; Moreau R; Durand F; Marcellin P; Rautou PE; Valla D
    Hepatology; 2014 Sep; 60(3):823-31. PubMed ID: 24841704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of Hepatitis B Virus Infection After Living-Donor Liver Transplant: A Single-center Experience Over 20 Years.
    Nafady-Hego H; Elgendy H; Nafady A; Uemoto S
    Exp Clin Transplant; 2016 Apr; 14(2):207-14. PubMed ID: 26867537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced liver cancer mortality with regular clinic follow-up among patients with chronic hepatitis B: A nationwide cohort study.
    Shim JJ; Kim GA; Oh CH; Kim JW; Myung J; Kim BH; Oh IH
    Cancer Med; 2020 Oct; 9(20):7781-7791. PubMed ID: 32857923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural History of Chronic Hepatitis B Virus Infection in Ahvaz City, Iran.
    Makvandi M; Soleimani Jelodar R; Samarbafzadeh A; Neisi N; Sharifi Z; Gholampour A; Masjedizadeh A; Shayesteh A
    Asian Pac J Cancer Prev; 2018 Aug; 19(8):2125-2129. PubMed ID: 30139211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death.
    Chen JD; Yang HI; Iloeje UH; You SL; Lu SN; Wang LY; Su J; Sun CA; Liaw YF; Chen CJ;
    Gastroenterology; 2010 May; 138(5):1747-54. PubMed ID: 20114048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients.
    Su TH; Hu TH; Chen CY; Huang YH; Chuang WL; Lin CC; Wang CC; Su WW; Chen MY; Peng CY; Chien RN; Huang YW; Wang HY; Lin CL; Yang SS; Chen TM; Mo LR; Hsu SJ; Tseng KC; Hsieh TY; Suk FM; Hu CT; Bair MJ; Liang CC; Lei YC; Tseng TC; Chen CL; Kao JH;
    Liver Int; 2016 Dec; 36(12):1755-1764. PubMed ID: 27634134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk and predictors of mortality associated with chronic hepatitis B infection.
    Iloeje UH; Yang HI; Jen CL; Su J; Wang LY; You SL; Chen CJ;
    Clin Gastroenterol Hepatol; 2007 Aug; 5(8):921-31. PubMed ID: 17678844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of occult hepatitis B virus infection on the outcome of chronic hepatitis C.
    Squadrito G; Cacciola I; Alibrandi A; Pollicino T; Raimondo G
    J Hepatol; 2013 Oct; 59(4):696-700. PubMed ID: 23751755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity and hepatocellular carcinoma in patients receiving entecavir for chronic hepatitis B.
    Lee J; Yoo SH; Sohn W; Kim HW; Choi YS; Won JH; Heo JY; Park SJ; Park YM
    Clin Mol Hepatol; 2016 Sep; 22(3):339-349. PubMed ID: 27729627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tenofovir, entecavir, and lamivudine in patients with severe acute exacerbation and hepatic decompensation of chronic hepatitis B.
    Park JG; Lee YR; Park SY; Lee HJ; Tak WY; Kweon YO; Jang SY; Chun JM; Han YS; Hur K; Lee HW; Kang MK
    Dig Liver Dis; 2018 Feb; 50(2):163-167. PubMed ID: 29089265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.